Physiological and pathophysiological roles ofAdiponectin receptors and identification of molecular targets for treatment of life-style related diseases
脂联素受体的生理和病理生理作用以及治疗生活方式相关疾病的分子靶标的鉴定
基本信息
- 批准号:18209033
- 负责人:
- 金额:$ 32.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adiponectin plays a central role as an antidiabetic and antiatherogenic adipokine. AdipoR1 and AdipoR2 serve as receptors for adiponectin in vitro, and their reduction in obesity seems to be correlated with reduced adiponectin sensitivity. In this study, we show that adenovirus-mediated expression of AdipoR1 and R2 in the liver of Lepr(-/-) mice increased AMP-activated protein kinase (AMPK) activation and peroxisome proliferator-activated receptor (PPAR)-alpha signaling pathways, respectively. Activation of AMPK reduced gluconeogenesis, whereas expression of the receptors in both cases increased fatty acid oxidation and lead to an amelioration of diabetes. Alternatively, targeted disruption of AdipoR1 resulted in the abrogation of adiponectin-induced AMPK activation, whereas that of AdipoR2 resulted in decreased activity of PPAR-alpha signaling pathways. Simultaneous disruption of both AdipoR1 and R2 abolished adiponectin binding and actions, resulting in increased tissue triglyceride … More content, inflammation and oxidative stress, and thus leading to insulin resistance and marked glucose intolerance. Therefore, AdipoR1 and R2 serve as the predominant receptors for adiponectin in vivo and play important roles in the regulation of glucose and lipid metabolism, inflammation and oxidative stress in vivo (Nat. Med. 13:332, 2007).We next examined the effects of adiponectin in the central nervous system, In this study, we show that adiponectin enhances AMPK activity in the arcuate hypothalamus (ARH) via its receptor AdipoR1 to stimulate food intake; this stimulation of food intake by adiponectin was attenuated by dominant-negative AMPK expression in the ARE Moreover, adiponectin also decreased energy expenditure. Adiponectin-deficient mice showed decreased AMPK phosphorylation in the ARH, decreased food intake, and increased energy expenditure, exhibiting resistance to high-fat-diet-induced obesity. Serum and cerebrospinal fluid levels of Adiponectin (Clin. Chem. 53:1541, 2007) and expression of AdipoR1 in the ARH were increased during fasting and decreased after refeeding. We conclude that adiponectin stimulates food intake and decreases energy expenditure during fasting through its effects in the central nervous system (Cell Metab. 6:55, 2007; FEBS Lett. 582:74, 2008). Less
脂联素作为一种抗糖尿病和抗动脉粥样硬化的脂肪因子发挥着核心作用。在体外,AdipoR1和AdipoR2是脂联素的受体,它们在肥胖中的减少似乎与脂联素敏感性的降低有关。在这项研究中,我们发现腺病毒介导的AdipoR1和R2在LepR(-/-)小鼠的肝脏中的表达分别增加了AMPK激活和PPAR-α信号通路。AMPK的激活减少了糖异生,而受体的表达在两种情况下都增加了脂肪酸氧化,并导致糖尿病的改善。另一种选择是,靶向阻断AdipoR1导致脂联素诱导的AMPK激活消失,而AdipoR2导致PPAR-α信号通路活性降低。同时破坏AdipoR1和R2取消了脂联素的结合和作用,导致组织甘油三酯…增加更多的内容,炎症和氧化应激,从而导致胰岛素抵抗和明显的葡萄糖耐受。因此,AdipoR1和R2是体内脂联素的主要受体,在体内糖脂代谢、炎症和氧化应激(NAT)的调节中发挥重要作用。地中海医院。我们接下来研究了脂联素在中枢神经系统中的作用,在这项研究中,我们发现脂联素通过其受体AdipoR1增强弓状下丘脑(ARH)的AMPK活性来刺激食物摄取;这种由脂联素刺激的食物摄入量被ARE中显性负AMPK表达减弱。此外,脂联素还减少了能量消耗。脂联素缺乏的小鼠表现出ARH中AMPK磷酸化减少,食物摄入量减少,能量消耗增加,表现出对高脂饮食诱导的肥胖的抵抗。血清和脑脊液脂联素水平(临床。化学。53:1541,2007),并且AdipoR1在ARH中的表达在禁食时增加,重新喂养后减少。我们得出结论,脂联素通过对中枢神经系统(细胞代谢)的影响,刺激食物的摄入,减少禁食期间的能量消耗。2007年6:55;FEBS Lett。582:74,2008)。较少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoRI and AdipoR2
脂联素通过其特异性膜受体AdipoRI和AdipoR2抑制胃癌的生长和腹膜转移
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ishikawa M;Kitayama J;Yamauchi T;Kadowaki T;Maki T;Miyato H;Yamashita H;Nagawa H.
- 通讯作者:Nagawa H.
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
- DOI:10.1038/nm1557
- 发表时间:2007-03-01
- 期刊:
- 影响因子:82.9
- 作者:Yamauchi, Toshimasa;Nio, Yasunori;Kadowaki, Takashi
- 通讯作者:Kadowaki, Takashi
The physiological and pathophysiological role of adiponectin and adiponectin receptoiCs in the peripheral tissues and CNS
脂联素和脂联素受体在外周组织和中枢神经系统中的生理和病理生理作用
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Kadowaki T;Yamauchi T;Kubota N.
- 通讯作者:Kubota N.
Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake
- DOI:10.1016/j.cmet.2007.06.003
- 发表时间:2007-07-01
- 期刊:
- 影响因子:29
- 作者:Kubota, Naoto;Yano, Wataru;Kadowaki, Takashi
- 通讯作者:Kadowaki, Takashi
Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoRl and AdipoR2
脂联素通过其特异性膜受体AdipoRl和AdipoR2抑制胃癌的生长和腹膜转移
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ishikawa M;Kitayama J;Yamauchi T;Kadowaki T;Maki T;Miyato H;Yamashita H;Nagawa H.
- 通讯作者:Nagawa H.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KADOWAKI Takashi其他文献
KADOWAKI Takashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KADOWAKI Takashi', 18)}}的其他基金
Comprehensive and expansive research of the universal metabolic regulation mechanisms for healthspan
对健康寿命的普遍代谢调节机制进行全面而广泛的研究
- 批准号:
26000012 - 财政年份:2014
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Specially Promoted Research
A comparison between Japanese men and US men with regard to change in abdominal adipose tissue and progression of subclinical atherosclerosis
日本男性和美国男性腹部脂肪组织变化和亚临床动脉粥样硬化进展的比较
- 批准号:
21590688 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrated elucidation of metabolic pathway in the physiology and pathology
生理病理代谢途径的综合阐明
- 批准号:
20229008 - 财政年份:2008
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Physiological and pathophysiological roles and signal transduction of adiponectin receptors
脂联素受体的生理和病理生理作用及信号转导
- 批准号:
16209030 - 财政年份:2004
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
The pathophysiological roles of adiponectin in the regulation of type 2 diabetes, hyperlipidemia and atherosclerosis
脂联素在调节2型糖尿病、高脂血症和动脉粥样硬化中的病理生理作用
- 批准号:
14207045 - 财政年份:2002
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Identification of type 2 diabetes susceptibility genes in the Japanese population by genome mapping and candidate gene approach and functional analysis
通过基因组作图、候选基因方法和功能分析鉴定日本人群中 2 型糖尿病易感基因
- 批准号:
14013008 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Development of novel diagnostic and therapeutic strategies for obesity and insulin resistance by identification of endogenous PPARγ ligands
通过鉴定内源性 PPARγ 配体开发肥胖和胰岛素抵抗的新型诊断和治疗策略
- 批准号:
12557093 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study for molecular mechanisms of obesity, insulin resistance and atherosclerosis in the PPAR gamma deficient mice
PPARγ缺陷小鼠肥胖、胰岛素抵抗和动脉粥样硬化的分子机制研究
- 批准号:
12470225 - 财政年份:2000
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of susceptibility genes for type 2 diabetes in the Japanese using affected sib pair analysis
使用受影响的同胞对分析鉴定日本人 2 型糖尿病的易感基因
- 批准号:
09557078 - 财政年份:1997
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Approach to the pathogenesis of NIDDM using knockout mouse models.
使用基因敲除小鼠模型探讨 NIDDM 的发病机制。
- 批准号:
09470215 - 财政年份:1997
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample
了解肿瘤微环境中肥胖和脂肪因子相关 RNA 表达对种族和民族多样化样本中乳腺癌结果的作用
- 批准号:
10602753 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10366023 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
- 批准号:
10580769 - 财政年份:2021
- 资助金额:
$ 32.28万 - 项目类别:
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
- 批准号:
10530591 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
Role of Adipokine FABP4 in Glucoregulation and Counter Regulatory Responses
脂肪因子 FABP4 在血糖调节和反调节反应中的作用
- 批准号:
10304199 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
A novel adipokine suppresses leptin signaling and promotes obesity
一种新型脂肪因子抑制瘦素信号传导并促进肥胖
- 批准号:
10327290 - 财政年份:2019
- 资助金额:
$ 32.28万 - 项目类别:
Regulation of white fat browning by a novel, brown fat-secreted adipokine
新型棕色脂肪分泌脂肪因子对白色脂肪褐变的调节
- 批准号:
9751849 - 财政年份:2018
- 资助金额:
$ 32.28万 - 项目类别:
adipokine and bladder cancer -new mechanisms of modulating PGE2
脂肪因子与膀胱癌——调节PGE2的新机制
- 批准号:
16K20143 - 财政年份:2016
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Adipokine Modulation of Fibrosis: Novel Scleroderma Pathway
纤维化的脂肪因子调节:硬皮病新途径
- 批准号:
8823417 - 财政年份:2015
- 资助金额:
$ 32.28万 - 项目类别:
Adipokines, adipokine receptors, and disparities in breast cancer clinicopathological features
脂肪因子、脂肪因子受体和乳腺癌临床病理特征的差异
- 批准号:
9884527 - 财政年份:2015
- 资助金额:
$ 32.28万 - 项目类别:














{{item.name}}会员




